| Product dosage: 0.03mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | $53.08 | $53.08 (0%) | 🛒 Add to cart |
| 2 | $50.58 | $106.17 $101.16 (5%) | 🛒 Add to cart |
| 3 | $50.08 | $159.25 $150.24 (6%) | 🛒 Add to cart |
| 4 | $49.83 | $212.34 $199.32 (6%) | 🛒 Add to cart |
| 5 | $49.48 | $265.42 $247.39 (7%) | 🛒 Add to cart |
| 6 | $49.41 | $318.51 $296.47 (7%) | 🛒 Add to cart |
| 7 | $49.22 | $371.59 $344.55 (7%) | 🛒 Add to cart |
| 8 | $49.20 | $424.68 $393.63 (7%) | 🛒 Add to cart |
| 9 | $49.19 | $477.76 $442.71 (7%) | 🛒 Add to cart |
| 10 | $49.08
Best per bottle | $530.85 $490.78 (8%) | 🛒 Add to cart |
Synonyms | |||
More info:
Lumigan: Effective Intraocular Pressure Reduction for Glaucoma - Evidence-Based Review
Lumigan is a prostaglandin analog ophthalmic solution containing bimatoprost as its active ingredient, primarily indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by increasing the outflow of aqueous humor through both the trabecular meshwork and uveoscleral pathways, offering a unique dual mechanism among IOP-lowering agents. What’s fascinating about this medication isn’t just its efficacy—which we’ll discuss extensively—but how it transformed from a glaucoma treatment to having unexpected cosmetic applications, something I witnessed firsthand during its early clinical adoption.
Xalatan: Effective Intraocular Pressure Control for Glaucoma - Evidence-Based Review
Latanoprost ophthalmic solution, marketed under the brand name Xalatan among others, represents a cornerstone in the pharmacological management of open-angle glaucoma and ocular hypertension. As a synthetic prostaglandin F2α analog, this medication works by increasing the outflow of aqueous humor through the uveoscleral pathway, effectively reducing intraocular pressure (IOP) – the primary modifiable risk factor in glaucoma progression. Unlike earlier therapies that focused on reducing aqueous production, latanoprost’s unique mechanism offers 24-hour control with once-daily dosing, making it a first-line treatment in clinical guidelines worldwide.
a ret gel
Product Description: A Ret Gel represents a significant advancement in topical retinoid therapy, combining stabilized tretinoin with enhanced penetration technology. This medical-grade formulation addresses the fundamental challenge of retinoid instability while maximizing bioavailability. The gel matrix creates a controlled-release environment that maintains tretinoin’s molecular integrity while minimizing the irritation commonly associated with traditional retinoid formulations. What sets this apart isn’t just the active ingredient—it’s the delivery system that makes the difference in clinical outcomes.
abana
Product Description: Abana represents one of those interesting formulations that bridges traditional Ayurvedic wisdom with modern cardiovascular science. I first encountered it during my cardiology fellowship when our department was exploring integrative approaches to lipid management. The formula combines herbs like Terminalia arjuna, Withania somnifera, and Ocimum sanctum with minerals in a specific preparation that’s been used for decades, though Western literature has been slow to catch up. ## 1. Introduction: What is Abana?
abhigra
Product Description Abhigra represents a novel class of phytopharmaceutical-grade dietary supplements derived from a standardized extract of Boswellia serrata, specifically optimized for enhanced bioavailability. Unlike conventional boswellia supplements, Abhigra utilizes a proprietary lipid-based delivery system that significantly increases the absorption of the active boswellic acids, particularly AKBA (3-O-acetyl-11-keto-β-boswellic acid). The formulation was developed through a collaboration between rheumatologists and pharmacognosy experts who recognized the limitations of existing anti-inflammatory supplements. We kept hitting the same wall with patients - they’d take standard boswellia products but achieve negligible serum levels.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. This second-generation antipsychotic functions as a partial dopamine D2 and serotonin 5-HT1A receptor agonist while simultaneously acting as a 5-HT2A receptor antagonist. The clinical implications of this mechanism are profound, offering stabilization of dopamine neurotransmission rather than complete blockade, which translates to improved tolerability regarding extrapyramidal symptoms and prolactin elevation compared to conventional antipsychotics.
Acamprol: Neurotransmitter Modulation for Cognitive and Neurological Support - Evidence-Based Review
Product Description Acamprol is an orally administered dietary supplement specifically formulated to support neurological health and cognitive function. It falls into the category of medical foods or nutraceuticals designed to provide targeted nutritional support for conditions involving neurotransmitter imbalance and neuronal excitability. The product is typically available in delayed-release tablet form, intended to ensure optimal absorption in the gastrointestinal tract. Its development was driven by the growing need for non-pharmaceutical interventions in managing functional neurological symptoms, particularly in cases where conventional medications are contraindicated or poorly tolerated.
Accufine: Continuous Glucose Monitoring Without Calibration - Evidence-Based Review
Product Description Accufine represents a significant advancement in non-invasive blood glucose monitoring technology. This Class II medical device utilizes a proprietary multi-sensor array with advanced photoplethysmography and impedance spectroscopy to provide continuous glucose readings without fingerstick calibration. The system consists of a discreet wearable sensor that transmits data to a dedicated mobile application, allowing patients and clinicians to track glycemic patterns in real-time. What sets Accufine apart isn’t just the technology itself, but how we arrived at this particular configuration - a journey marked by both breakthroughs and considerable setbacks that nearly derailed the project entirely.
accupril
Accupril is a well-established angiotensin-converting enzyme (ACE) inhibitor, specifically quinapril hydrochloride, used primarily in the management of hypertension and as adjunctive therapy in heart failure. It works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing aldosterone secretion, which decreases sodium and water retention. This monograph provides a comprehensive, evidence-based review of Accupril, detailing its clinical applications, pharmacokinetics, safety profile, and practical considerations for use, aimed at healthcare professionals and informed patients seeking in-depth understanding.